1801 - 1850 of 9030 Results
Title
Year
-
OPENTitle: Efficient estimation of nonparametric genetic risk function with censored dataJournal Name: BiometrikaPublisher: Oxford University Press (OUP)Vol: 102Issue #: 3Start Page: 515End Page: 532Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/biomet/asv030Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4581539Citation Count: 7
- Synthesis and SAR of novel, 4-(phenylsulfamoyl)phenylacetamide mGlu4 positive allosteric modulators (PAMs) identified by functional high-throughput screening (HTS)2010OPENTitle: Synthesis and SAR of novel, 4-(phenylsulfamoyl)phenylacetamide mGlu4 positive allosteric modulators (PAMs) identified by functional high-throughput screening (HTS)Journal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 20Issue #: 17Start Page: 5175End Page: 5178Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2010.07.007Citation Count: 29
-
OPENTitle: Synthesis and SAR of a novel positive allosteric modulator (PAM) of the metabotropic glutamate receptor 4 (mGluR4)Journal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 19Issue #: 17Start Page: 4967End Page: 4970Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2009.07.072Best OA location URL: http://doi.org/10.1016/j.bmcl.2009.07.072Citation Count: 38
-
OPENTitle: Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4): Part I. Discovery of pyrazolo[3,4-d]pyrimidines as novel mGluR4 positive allosteric modulatorsJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 18Issue #: 20Start Page: 5626End Page: 5630Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2008.08.087Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3182458Citation Count: 58
- Synthesis and SAR of a novel metabotropic glutamate receptor 4 (mGlu4) antagonist: Unexpected ‘molecular switch’ from a closely related mGlu4 positive allosteric modulator2011OPENTitle: Synthesis and SAR of a novel metabotropic glutamate receptor 4 (mGlu4) antagonist: Unexpected ‘molecular switch’ from a closely related mGlu4 positive allosteric modulatorJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 21Issue #: 23Start Page: 6955End Page: 6959Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2011.09.131Citation Count: 18
-
OPENTitle: Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4). Part II: Challenges in hit-to-leadJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 19Issue #: 3Start Page: 962End Page: 966Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2008.11.104Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3787871Citation Count: 58
-
OPENTitle: Discovery and characterization of a novel series of N-phenylsulfonyl-1H-pyrrole picolinamides as positive allosteric modulators of the metabotropic glutamate receptor 4 (mGlu4)Journal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 26Issue #: 13Start Page: 2984End Page: 2987Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2016.05.029Best OA location URL: http://doi.org/10.1016/j.bmcl.2016.05.029Citation Count: 5
-
OPENTitle: Development and evaluation of [18F]Flotaza for Aβ plaque imaging in postmortem human Alzheimer’s disease brainJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 46Issue #:Start Page: 128164End Page: 128164Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2021.128164Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8379902Citation Count: 15
-
OPENTitle: Toxic Oligomeric Alpha-Synuclein Variants Present in Human Parkinson’s Disease Brains Are Differentially Generated in Mammalian Cell ModelsJournal Name: BiomoleculesPublisher: MDPI AGVol: 5Issue #: 3Start Page: 1634End Page: 1651Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom5031634Best OA location URL: http://hdl.handle.net/2286/R.I.43313Citation Count: 39
-
OPENTitle: Conformational heterogeneity of the Roc domains in C. tepidum Roc–COR and implications for human LRRK2 Parkinson mutationsJournal Name: Bioscience ReportsPublisher: Portland Press Ltd.Vol: 35Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bsr20150128Best OA location URL: https://portlandpress.com/bioscirep/article-pdf/35/5/e00254/477473/bsr035e254.pdfCitation Count: 27
-
OPENTitle: Identifying blood-brain-barrier selective single-chain antibody fragmentsJournal Name: Biotechnology JournalPublisher: WileyVol: 9Issue #: 5Start Page: 664End Page: 674Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/biot.201300550Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4073886Citation Count: 23
-
OPENTitle: Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samplesJournal Name: Biotechnology ProgressPublisher: WileyVol: 29Issue #: 2Start Page: 463End Page: 471Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/btpr.1698Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3618510Citation Count: 24
-
OPENTitle: Normalization and expression changes in predefined sets of proteins using 2D gel electrophoresis: A proteomic study of L-DOPA induced dyskinesia in an animal model of Parkinson's disease using DIGEJournal Name: BMC BioinformaticsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page: 475End Page: 475Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/1471-2105-7-475Best OA location URL: https://bmcbioinformatics.biomedcentral.com/counter/pdf/10.1186/1471-2105-7-475Citation Count: 38
-
OPENTitle: A pipeline for RNA-seq based eQTL analysis with automated quality control proceduresJournal Name: BMC BioinformaticsPublisher: Springer Science and Business Media LLCVol: 22Issue #: S9Start Page: 403End Page: 403Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12859-021-04307-0Best OA location URL: https://bmcbioinformatics.biomedcentral.com/track/pdf/10.1186/s12859-021-04307-0Citation Count: 40
-
OPENTitle: Cost effectiveness of preventing falls and improving mobility in people with Parkinson disease: protocol for an economic evaluation alongside a clinical trialJournal Name: BMC GeriatricsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 23End Page: 23Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/1471-2318-8-23Best OA location URL: https://bmcgeriatr.biomedcentral.com/track/pdf/10.1186/1471-2318-8-23Citation Count: 29
-
OPENTitle: Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairmentJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 146End Page: 146Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1186/s12883-015-0403-4Best OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-015-0403-4Citation Count: 58
- Progression of motor and nonmotor features of Parkinson's disease and their response to treatment2012RESTRICTEDTitle: Progression of motor and nonmotor features of Parkinson's disease and their response to treatmentJournal Name: British Journal of Clinical PharmacologyPublisher: WileyVol: 74Issue #: 2Start Page: 267End Page: 283Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1365-2125.2012.04192.xCitation Count: 186
-
OPENTitle: Exercise response in Parkinson’s disease: insights from a cross-sectional comparison with sedentary controls and a per-protocol analysis of a randomised controlled trialJournal Name: BMJ OpenPublisher: BMJVol: 7Issue #: 12Start Page: e017194End Page: e017194Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2017-017194Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/7/12/e017194.full.pdfCitation Count: 38
- Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease2012RESTRICTEDTitle: Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's diseaseJournal Name: British Journal of Clinical PharmacologyPublisher: WileyVol: 74Issue #: 2Start Page: 284End Page: 295Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1365-2125.2012.04208.xCitation Count: 46
-
OPENTitle: MPP+‐dependent inhibition of Ih reduces spontaneous activity and enhances EPSP summation in nigral dopamine neuronsJournal Name: British Journal of PharmacologyPublisher: WileyVol: 169Issue #: 1Start Page: 130End Page: 142Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/bph.12104Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.12104Citation Count: 29
- Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity2005OPENTitle: Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicityJournal Name: BMC NeurosciencePublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page: 71End Page: 71Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/1471-2202-6-71Best OA location URL: https://bmcneurosci.biomedcentral.com/counter/pdf/10.1186/1471-2202-6-71Citation Count: 66
-
OPENTitle: Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐upJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 8Start Page: e2257End Page: e2257Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2257Best OA location URL: https://doi.org/10.1002/brb3.2257Citation Count: 19
-
OPENTitle: The Parkinson’s Disease Comprehensive Response (PDCORE): a composite approach integrating three standard outcome measuresJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 2Issue #: 2Start Page: fcaa046End Page: fcaa046Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaa046Best OA location URL: https://academic.oup.com/braincomms/article-pdf/2/2/fcaa046/35118141/fcaa046.pdfCitation Count: 13
-
OPENTitle: Pyk2 overexpression in postsynaptic neurons blocks amyloid β1–42-induced synaptotoxicity in microfluidic co-culturesJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 2Issue #: 2Start Page: fcaa139End Page: fcaa139Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaa139Best OA location URL: https://academic.oup.com/braincomms/article-pdf/2/2/fcaa139/36458145/fcaa139.pdfCitation Count: 27
-
OPENTitle: Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 3Issue #: 2Start Page: fcab109End Page: fcab109Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcab109Best OA location URL: https://academic.oup.com/braincomms/article-pdf/3/2/fcab109/41723515/fcab109.pdfCitation Count: 49
-
OPENTitle: Long-term success of low-frequency subthalamic nucleus stimulation for Parkinson’s disease depends on tremor severity and symptom durationJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 3Issue #: 3Start Page: fcab165End Page: fcab165Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcab165Best OA location URL: https://academic.oup.com/braincomms/article-pdf/3/3/fcab165/39604424/fcab165.pdfCitation Count: 11
-
OPENTitle: Deep learning-based brain transcriptomic signatures associated with the neuropathological and clinical severity of Alzheimer’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 4Issue #: 1Start Page: fcab293End Page: fcab293Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcab293Best OA location URL: https://academic.oup.com/braincomms/article-pdf/4/1/fcab293/42475382/fcab293.pdfCitation Count: 27
-
OPENTitle: Task-rest modulation of basal ganglia connectivity in mild to moderate Parkinson’s diseaseJournal Name: Brain Imaging and BehaviorPublisher: Springer Science and Business Media LLCVol: 9Issue #: 3Start Page: 619End Page: 638Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11682-014-9317-9Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4385510Citation Count: 33
-
OPENTitle: Involvement of Perineuronal and Perisynaptic Extracellular Matrix in Alzheimer's Disease NeuropathologyJournal Name: Brain PathologyPublisher: WileyVol: 22Issue #: 4Start Page: 547End Page: 561Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1750-3639.2011.00557.xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3639011Citation Count: 151
- Biochemical Increase in Phosphorylated Alpha‐Synuclein Precedes Histopathology of Lewy‐Type Synucleinopathies2012RESTRICTEDTitle: Biochemical Increase in Phosphorylated Alpha‐Synuclein Precedes Histopathology of Lewy‐Type SynucleinopathiesJournal Name: Brain PathologyPublisher: WileyVol: 22Issue #: 6Start Page: 745End Page: 756Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1750-3639.2012.00585.xCitation Count: 75
-
OPENTitle: Investigation of pathology, expression and proteomic profiles in human TREM2 variant postmortem brains with and without Alzheimer’s diseaseJournal Name: Brain PathologyPublisher: WileyVol: 30Issue #: 4Start Page: 794End Page: 810Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/bpa.12842Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bpa.12842Citation Count: 15
-
RESTRICTEDTitle: Age-related changes in glutathione and glutathione-related enzymes in rat brainJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1090Issue #: 1Start Page: 35End Page: 44Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2006.03.063Best OA location URL: http://doi.org/10.1016/j.brainres.2006.03.063Citation Count: 276
-
OPENTitle: CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1408Issue #:Start Page: 88End Page: 97Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2011.06.057Best OA location URL: http://doi.org/10.1016/j.brainres.2011.06.057Citation Count: 78
- Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease2010RESTRICTEDTitle: Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1367Issue #:Start Page: 310End Page: 318Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2010.08.099Citation Count: 47
- Changes in attack behavior and activity in EphA5 knockout mice2008RESTRICTEDTitle: Changes in attack behavior and activity in EphA5 knockout miceJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1205Issue #:Start Page: 91End Page: 99Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2008.02.047Citation Count: 24
-
RESTRICTEDTitle: Allopurinol reduces levels of urate and dopamine but not dopaminergic neurons in a dual pesticide model of Parkinson׳s diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1563Issue #:Start Page: 103End Page: 109Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2014.03.031Best OA location URL: http://doi.org/10.1016/j.brainres.2014.03.031Citation Count: 19
-
OPENTitle: Critical Role of Truncated α‐Synuclein and Aggregates in Parkinson's Disease and Incidental Lewy Body DiseaseJournal Name: Brain PathologyPublisher: WileyVol: 22Issue #: 6Start Page: 811End Page: 825Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1750-3639.2012.00597.xBest OA location URL: http://doi.org/10.1111/j.1750-3639.2012.00597.xCitation Count: 64
- Dysrhythmia of timed movements in Parkinson׳s disease and freezing of gait2015OPENTitle: Dysrhythmia of timed movements in Parkinson׳s disease and freezing of gaitJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1624Issue #:Start Page: 222End Page: 231Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2015.07.041Citation Count: 38
-
OPENTitle: Hypermethylation of Synphilin-1, Alpha-Synuclein-Interacting Protein (SNCAIP) Gene in the Cerebral Cortex of Patients with Sporadic Parkinson’s DiseaseJournal Name: Brain SciencesPublisher: MDPI AGVol: 7Issue #: 7Start Page: 74End Page: 74Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci7070074Best OA location URL: https://www.mdpi.com/2076-3425/7/7/74/pdf?version=1500945204Citation Count: 27
- Deep brain stimulation effect on anterior pallidum reduces motor impulsivity in Parkinson's disease2021OPENTitle: Deep brain stimulation effect on anterior pallidum reduces motor impulsivity in Parkinson's diseaseJournal Name: Brain StimulationPublisher: Elsevier BVVol: 15Issue #: 1Start Page: 23End Page: 31Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.brs.2021.11.006Best OA location URL: https://doi.org/10.1016/j.brs.2021.11.006Citation Count: 10
-
OPENTitle: Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 132Issue #: 7Start Page: 1783End Page: 1794Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awp044Best OA location URL: https://academic.oup.com/brain/article-pdf/132/7/1783/13734818/awp044.pdfCitation Count: 703
-
OPENTitle: Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 131Issue #: 7Start Page: 1880End Page: 1894Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awn101Best OA location URL: https://academic.oup.com/brain/article-pdf/131/7/1880/1093630/awn101.pdfCitation Count: 340
-
OPENTitle: Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 134Issue #: 8Start Page: 2358End Page: 2365Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awr139Best OA location URL: https://academic.oup.com/brain/article-pdf/134/8/2358/1015592/awr139.pdfCitation Count: 115
-
OPENTitle: Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: implications for the development of dyskinesiaJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 134Issue #: 8Start Page: 2339End Page: 2357Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awr165Best OA location URL: https://academic.oup.com/brain/article-pdf/134/8/2339/13735225/awr165.pdfCitation Count: 139
-
OPENTitle: Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 135Issue #: 11Start Page: 3355End Page: 3370Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/aws254Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gs-1/9499Citation Count: 170
-
OPENTitle: Nigral stimulation for resistant axial motor impairment in Parkinson’s disease? A randomized controlled trialJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 136Issue #: 7Start Page: 2098End Page: 2108Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awt122Best OA location URL: https://academic.oup.com/brain/article-pdf/136/7/2098/13795851/awt122.pdfCitation Count: 215
- Thalamic cholinergic innervation and postural sensory integration function in Parkinson’s disease2013OPENTitle: Thalamic cholinergic innervation and postural sensory integration function in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 136Issue #: 11Start Page: 3282End Page: 3289Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awt247Best OA location URL: https://academic.oup.com/brain/article-pdf/136/11/3282/11138755/awt247.pdfCitation Count: 187
- Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding study2015OPENTitle: Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding studyJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 138Issue #: 4Start Page: 963End Page: 973Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awu409Best OA location URL: https://kclpure.kcl.ac.uk/ws/files/148083964/Eltoprazine_counteracts_L_DOPA_induced_SVENNINGSSON_Publishedonline5February2015_GOLD_VoR_CC_BY_NC_.pdfCitation Count: 160
-
OPENTitle: Subthalamic stimulation modulates cortical motor network activity and synchronization in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 138Issue #: 3Start Page: 679End Page: 693Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awu380Best OA location URL: https://academic.oup.com/brain/article-pdf/138/3/679/13799397/awu380.pdfCitation Count: 82
-
OPENTitle: Loss of SYNJ1 dual phosphatase activity leads to early onset refractory seizures and progressive neurological declineJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 139Issue #: 9Start Page: 2420End Page: 2430Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/aww180Best OA location URL: https://academic.oup.com/brain/article-pdf/139/9/2420/17944760/aww180.pdfCitation Count: 82